andrewdudum

Founder & CEO $HIMS.

[andrewdudum @AndrewDudum]

@Butler22789 @lucidjp Shoot me a note or maybe order ID so i can have the team look into this!

[andrewdudum @AndrewDudum]

Note on forward-looking statements:
https://t.co/OWT5gw5s7V

[andrewdudum @AndrewDudum]

Today, I’m so proud to share that we're a strategic investor in Arboretum LifeSciences, a next-generation molecular information company. They’re combining genetic testing and AI to scale precision medicine to more conditions and more people.

Since meeting the Arboretum team, I have been looking for ways to be a part of getting their innovation into more hands for one simple reason. Giving people the tools to understand their risk before symptoms develop is how you transform a sickcare system into a healthcare system.

Understanding your own risk should be a normal part of care, not the exception. It’s the future of health that I believe in and it’s what Hims & Hers is all about. Health that gets smarter over time, adapts with you, and puts actionable information in your hands.

This goes beyond rare diseases and can fundamentally change how common conditions like heart disease, diabetes, and neurodegeneration are managed. Today, Arboretum is working with health systems and their providers, and I’m excited for the day that this kind of innovation extends beyond the traditional system (more to come here from us).

Congrats to Anthony, Clare, and the entire Arboretum team!

https://t.co/THEVkfw1Zr

[andrewdudum @AndrewDudum]

@Investinc_Intel Good catch!

[andrewdudum @AndrewDudum]

@vladtenev Very cool

[andrewdudum @AndrewDudum]

@Investinc_Intel Total refresh expected soon, fully rebuilt

[andrewdudum @AndrewDudum]

Today, Hims is live in Australia.

Proud to work with @_Timdoyle and the team. So much more to come. 🇦🇺

[Tim Doyle @_Timdoyle]

Men’s health has changed a lot in the seven years since we founded Pilot.

There was a widespread belief that men did not care about their health, and that solving for discretion and convenience was the only way to reach them.

That world has changed. Men care more, expect more and understand that the investments they make in their health pay off in how they feel, how they look and how they perform.

Today, Pilot becomes Hims, and we’re raising our ambition to meet the needs of Australian men through personalised preventative care.

I co-founded Eucalyptus on the belief that healthcare’s biggest opportunity isn’t the hospital—it’s everything that happens before you need one. That’s the same belief we’re taking into this next phase of growth.

Current Pilot customers will keep the local care team they already trust. They’re now part of a platform serving millions of men worldwide.

I’m proud of what we’ve built and excited for what’s next: https://t.co/fK4DTiPESP

[andrewdudum @AndrewDudum]

@himshouse Team is all over this. Hoping to get it resolved quickly but a bit backlogged due to raw ingredient supply chain dynamics

[andrewdudum @AndrewDudum]

My conversation on @SquawkCNBC covered everything from how we make accessing care more affordable to how AI is transforming healthcare, and why data is the most powerful tool we have for putting people in charge of their own health.

But more than anything, we discussed how dramatically different experiences can be on a platform that knows you well enough to help you act long before you're in a crisis.

When healthcare feels like concierge medicine without costing like it, that’s when real transformation starts. Great to chat with you, @andrewrsorkin.

https://t.co/062aRxKCnB

[NYSE 🏛 @NYSE]

Helping the world feel great through the power of better health.

Here's to 5 years of being NYSE-Listed 🔔 $HIMS
@wearehims | @wearehers

[andrewdudum @AndrewDudum]

This morning, we rang the Opening Bell at the @NYSE to celebrate 5 years of being listed. But we’re also marking our next phase of growth.

When we made the decision to take the company public, it was an intentional choice to put the company in a high-stakes arena that requires us to be excellent at both delivering on quarterly targets and meeting a long-term vision.

We also knew that some of the world’s most influential companies, like Amazon and Google, made the same choice soon after their founding because they knew they didn’t just have a valuable business. They had a vision to change an entire industry.

For us, that’s truer today than it was in January 2021 (and we’re still in the early innings).

A huge thanks to the entire Hims & Hers team, who made this moment possible and who will be the reason we change what healthcare looks and feels like around the world.

[NYSE 🏛 @NYSE]

The NYSE welcomes Hims & Hers to celebrate its 5th anniversary of listing! $HIMS

@wearehims | @wearehers https://t.co/0qoNc9Bhye

[andrewdudum @AndrewDudum]

@realChewyFanboy @RatCatDoge @weary_centurion Great to hear even newer version dropping soon. Totally updated

[Shy Nass @ShyGuy82433]

Getting evaluated for an autoimmune & found out a biomarker test wasn’t covered. Now I owe $335.10 OOP—with no warning.
This is what’s wrong w/ US healthcare.

Why I think $HIMS is the future: Labs had upfront pricing, what tests, and no surprise bills. @himshouse @AndrewDudum

[andrewdudum @AndrewDudum]

Important info here:
https://t.co/w7EJhKBXIn

[andrewdudum @AndrewDudum]

Q2 Earnings are live! With an accelerating US business and an expanding global reach, our position as the leading global consumer health platform means we have a responsibility to keep pushing the industry forward.

Nearly 3 million people now trust us with some of the most personal decisions of their lives, and we’ve spent nine years earning that, one relationship at a time. But what comes next takes it a step further.

We're making a multi-year commitment to build something novel in our industry: a doctor-led, AI-native care experience that knows you, keeps providers in charge of your care, and gets smarter every day.

The future of health won't be built by the companies with the best algorithms. It will be built by the ones that make world-class care fully integrated, deeply personal, and incredibly accessible for millions of people around the world.

We’re doing that, and it’s only the beginning.

https://t.co/4N5SbUpMSo

[andrewdudum @AndrewDudum]

We’ve wrapped up another busy quarter, and our retail community always asks the right questions. Send yours to [email protected] this weekend and we'll answer the most popular live on Monday afternoon.

[andrewdudum @AndrewDudum]

@TravisHoium @wearehims Mind messaging me directly so I can figure out how this got missed? Sorry about this!

[andrewdudum @AndrewDudum]

Healthcare built for real life requires a complete reinvention of the current experience. Not an add-on feature or a retrofit. Starting today, we’re launching a fundamental reimagining of what it means to get people closer to feeling great.

@wearehers weight loss members are the first ones to feel it today, and we’re planning to bring it to all of our members soon.

Watch this space. We’re just getting started.

[Hims & Hers Comms @HimsHersComms]

In healthcare, AI usually sits outside of care. It can answer a question, but it doesn't know your treatment plan or your doctor.

Today, that changes for @wearehers weight loss members. Our new doctor-led, AI-native care experience puts women, their providers, Care Teams, and AI in one ongoing conversation. This is intelligence embedded at every step of the care experience – personally tailored to track progress over time and help women reach their goals on their own terms.

https://t.co/tgb29j3NnW

Read more below, including important disclaimers.

[Hims & Hers Comms @HimsHersComms]

The FDA's Pharmacy Compounding Advisory Committee (PCAC) concluded its two-day review with a split recommendation. Read @dranantmd statement: https://t.co/4Zr5MyppFi

[Eric Bryant | Multibagger Research @MultibaggerRsch]

I got my second $HIMS labs back.

As a result of my first labs I made some significant lifestyle changes to improve my health and they have shown up in my results so far.

$HIMS labs is truely a game changer.